logo
welcome
Live Science

Live Science

When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says.

Live Science
Summary
Nutrition label

75% Informative

Dr. Albino Oliveira-Maia and colleagues reviewed 45 studies of psychedelics.

They found that many barely touched on the psychotherapy being provided alongside the drugs.

This is a big problem, which factored into the FDA 's decision to reject an MDMA -assisted therapy for PTSD this summer.

AO-M: I think people have a sense that the setting is important with drugs that induce a trip.

If we conclude that psychedelic-assisted therapy is very convoluted in the strategies that are necessary for its application, it's almost doomed to become a relatively niche intervention for very rich people in very rich countries.

The next potential approval would be psilocybin for depression, or treatment-resistant depression.

VR Score

83

Informative language

85

Neutral language

65

Article tone

informal

Language

English

Language complexity

55

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived